2.19. Time-resolved fluorescence resonance energy transfer (TR-FRET) assays in vitro

SA Shahar Azar
SU Shiran Udi
AD Adi Drori
RH Rivka Hadar
AN Alina Nemirovski
KV Kiran V. Vemuri
MM Maya Miller
DS Dana Sherill-Rofe
YA Yhara Arad
DG Devorah Gur-Wahnon
XL Xiaoling Li
AM Alexandros Makriyannis
DB Danny Ben-Zvi
YT Yuval Tabach
IB Iddo Z. Ben-Dov
JT Joseph Tam
request Request a Protocol
ask Ask a question
Favorite

To measure ligand binding to PPARα, TR-FRET was performed with a LanthaScreen TR-FRET PPARα competitive binding assay according to the manufacturer's instructions (Invitrogen). Briefly, a serial dilution of AM6545 and GW7647, a selective PPARα agonist, was prepared in a 384-well polypropylene assay plate. Fluormone Pan-PPAR Green, PPARα-LBD, and terbium (Tb)-labeled anti-GST Abs were then added to each sample. The assay plate was incubated for 2 h at room temperature prior to measuring the 520 nm/495 nm emission ratio of each well using an Infinite F500 microplate reader (Tecan, Männedorf, Switzerland) with instrument settings as described in the manufacturer's instructions for LanthaScreen assays.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A